GeneDx Holdings Corp.WGSNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank19
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P19
Within normal range
vs 2Y Ago
-3.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-125.93%
Q3 2025-171.05%
Q2 2025265.22%
Q1 2025-215.00%
Q4 2024164.52%
Q3 202471.82%
Q2 2024-41.03%
Q1 202421.21%
Q4 202339.63%
Q3 202310.87%
Q2 202339.47%
Q1 202388.41%
Q4 2022-290.33%
Q3 202219.81%
Q2 20223.79%
Q1 2022-58.65%
Q4 2021-198.39%
Q3 2021120.63%
Q2 202176.34%
Q1 2021-52.59%
Q4 2020-121.98%
Q3 20200.00%